• Mutation; HGNC; HGNC:644; AR; Simple; p.His875Tyr (c.2623C>T); ClinVar=VCV000009834; Zygosity=Hemizygous (from child cell line CWR22Pc).
  

PubMed=8433392; DOI=10.1093/jnci/85.5.394
Pretlow T.G. 2nd, Wolman S.R., Micale M.A., Pelley R.J., Kursh E.D., Resnick M.I., Bodner D.R., Jacobberger J.W., Delmoro C.M., Giaconia J.M., Pretlow T.P.
Xenografts of primary human prostatic carcinoma.
J. Natl. Cancer Inst. 85:394-398(1993)

PubMed=7525052
Wainstein M.A., He F., Robinson D., Kung H.-J., Schwartz S., Giaconia J.M., Edgehouse N.L., Pretlow T.P., Bodner D.R., Kursh E.D., Resnick M.I., Seftel A., Pretlow T.G. 2nd
CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma.
Cancer Res. 54:6049-6052(1994)

PubMed=8674060
Nagabhushan M., Miller C.M., Pretlow T.P., Giaconia J.M., Edgehouse N.L., Schwartz S., Kung H.-J., deVere White R.W., Gumerlock P.H., Resnick M.I., Amini S.B., Pretlow T.G. 2nd
CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar.
Cancer Res. 56:3042-3046(1996)

PubMed=10861745; DOI=10.1002/1097-0045(20000601)43:4<263::AID-PROS5>3.0.CO;2-I
van Weerden W.M., Romijn J.C.
Use of nude mouse xenograft models in prostate cancer research.
Prostate 43:263-271(2000)

PubMed=23671654; DOI=10.1371/journal.pone.0063056; PMCID=PMC3646030
Lu Y.-H., Soong T.D., Elemento O.
A novel approach for characterizing microsatellite instability in cancer cells.
PLoS ONE 8:E63056-E63056(2013)